Metraipolis › archive › dc_ef9fda91be97

The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage… — Europe PMC PMID:41726776

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41726776
DOI: 10.3389/fpubh.2025.1571980
License (as archived): solo-consultazione
Archived: 2026-11-06T02:46:35.625Z
SHA-256 of the archived text: c98288565f14fed90cdde0ad18ef21d8a7f6c5933e8329760f63df7ee68bb24e
Stable URL of this page: https://metraipolis.com/documento/dc_ef9fda91be97

How to cite

The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage… — Europe PMC PMID:41726776 — Europe PMC (en), https://europepmc.org/article/MED/41726776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef9fda91be97 (Metraipolis archive dc_ef9fda91be97, sha256 c98288565f14fed90cdde0ad18ef21d8a7f6c5933e8329760f63df7ee68bb24e)

BibTeX

@misc{dcef9fda91be97,
  title = {The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage… — Europe PMC PMID:41726776},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41726776},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef9fda91be97; sha256 c98288565f14fed90cdde0ad18ef21d8a7f6c5933e8329760f63df7ee68bb24e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41726776. Agents can read the archived copy with the MCP tool read_document.